Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001-2013

Gastroenterology

Volumn 149, Issue 6, 2015, Pages 1471-1482.e5

  Beste, Lauren A ^a,b   Leipertz, Steven L ^a   Green, Pamela K ^a   Dominitz, Jason A ^a,c   Ross, David ^d   Ioannou, George N ^a,c  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Diabetes; Hepatitis B Virus; NASH; Obesity

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BODY MASS; CANCER MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; ICD-9; INCIDENCE; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREND STUDY; UNITED STATES; VERY ELDERLY; VETERAN; CARCINOMA, HEPATOCELLULAR; COMPLICATION; HEPACIVIRUS; LIVER DISEASES, ALCOHOLIC; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOGENICITY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; VETERANS;

EID: 84945544435     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.07.056     Document Type: Article

References (36)

1. F. Kanwal, T. Hoang, J.R. Kramer, and et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection Gastroenterology 140 2011 1182 1188
2. S. Mittal, Y.H. Sada, H.B. El-Serag, and et al. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population Clin Gastroenterol Hepatol 13 2015 594 601
3. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
4. H.B. El-Serag, J.A. Davila, N.J. Petersen, and et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 2003 817 823
5. G.L. Armstrong, M.J. Alter, G.M. McQuillan, and et al. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States Hepatology 31 2000 777 782
6. A. Wasley, S. Grytdal, K. Gallagher, and et al. Surveillance for acute viral hepatitis - United States, 2006 MMWR Surveill Summ 57 2008 1 24
7. G.L. Davis, M.J. Alter, H. El-Serag, and et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression Gastroenterology 138 2010 513 521
8. S.F. Altekruse, S.J. Henley, J.E. Cucinelli, and et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States Am J Gastroenterol 109 2014 542 553
9. B. Njei, Y. Rotman, I. Ditah, and et al. Emerging trends in hepatocellular carcinoma incidence and mortality Hepatology 61 2015 191 199
10. National Center for Veterans Analysis and Statistics. Number of veteran patients by healthcare priority group: FY 2000 to FY 2013. Available at: http://www.va.gov/vetdata/Utilization.asp. Accessed September 9, 2014.
11. http://vaww.vinci.med.va.gov/vincicentral/overview.aspx. Last accessed 6/1/2012.
12. J.R. Kramer, J.A. Davila, E.D. Miller, and et al. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases Aliment Pharmacol Ther 27 2008 274 282
13. G.N. Ioannou, M.F. Splan, N.S. Weiss, and et al. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis Clin Gastroenterol Hepatol 5 2007 938 945
14. J.A. Davila, L. Henderson, J.R. Kramer, and et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States Ann Intern Med 154 2011 85 93
15. H.B. El-Serag, M.L. Johnson, C. Hachem, and et al. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes Gastroenterology 136 2009 1601 1608
16. D.R. Miller, M.M. Safford, and L.M. Pogach Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data Diabetes Care 27 Suppl 2 2004 B10 21
17. M.S. Ascha, I.A. Hanouneh, R. Lopez, and et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 2010 1972 1978
18. P.S. Kamath, R.H. Wiesner, M. Malinchoc, and et al. A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
19. B.D. Smith, R.L. Morgan, G.A. Beckett, and et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR Recomm Rep 61 2012 1 32
20. D.B. Rein, B.D. Smith, J.S. Wittenborn, and et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings Ann Intern Med 156 2012 263 270
21. K.N. Ly, J. Xing, R.M. Klevens, and et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 2012 271 278
22. S. Ratib, J. West, C.J. Crooks, and et al. Diagnosis of liver cirrhosis in England, a cohort study, 1998-2009: a comparison with cancer Am J Gastroenterol 109 2014 190 198
23. J.M. Hui, A. Sud, G.C. Farrell, and et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected] Gastroenterology 125 2003 1695 1704
24. L.E. Adinolfi, R. Utili, A. Andreana, and et al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C Dig Dis Sci 46 2001 1677 1683
25. T. Poynard, V. Ratziu, J. McHutchison, and et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C Hepatology 38 2003 75 85
26. L.A. Beste, and G.N. Ioannou Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs Epidemiol Rev 37 2015 131 143
27. M.M. Denniston, R.M. Klevens, G.M. McQuillan, and et al. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 Hepatology 55 2012 1652 1661
28. S.D. Holmberg, P.R. Spradling, A.C. Moorman, and et al. Hepatitis C in the United States N Engl J Med 368 2013 1859 1861
29. J.A. Dominitz, E.J. Boyko, T.D. Koepsell, and et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers Hepatology 41 2005 88 96
30. S.R. Das, L.S. Kinsinger, W.S. Yancy Jr., and et al. Obesity prevalence among veterans at Veterans Affairs medical facilities Am J Prev Med 28 2005 291 294
31. K.E. Delaney, A.K. Lee, G.T. Lapham, and et al. Inconsistencies between alcohol screening results based on AUDIT-C scores and reported drinking on the AUDIT-C questions: prevalence in two US national samples Addict Sci Clin Pract 9 2014 2
32. B.P. Bell, M.M. Manos, A. Zaman, and et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance Am J Gastroenterol 103 2008 2727 2736 quiz 2737
33. National Hepatitis C Registry Reports 2013. Available at: http://vaww.hepatitis.va.gov/data-reports/ccr-index.asp. Accessed October 3, 2014.
34. L.I. Backus, and P.S. Belperio Impact of sustained virologic response on all-cause mortality Hepatology 58 2013 1508 1510
35. A.J. van der Meer, B.J. Veldt, J.J. Feld, and et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis JAMA 308 2012 2584 2593
36. T.R. Morgan, M.G. Ghany, H.Y. Kim, and et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C Hepatology 52 2010 833 844